Olanzapine in bipolar disorder

Bibliography

• TOHEN M, ZHANG F, TAYLOR CC et al.: A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. .1. Affect. Disord. (2001) 65(1):85–93.
   Google Scholar
• KECK PE JR, MC ELROY SL, STRAKOWSKI SM et al.: Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. .1. Clin. Psychiatry (1996) 57:147–151.
   Google Scholar
• ZARATE CA, TOHEN M: Antipsychotic drug treatment in first-episode mania: a 6 month longitudinal study. I Clin. Psychiatry (2000) 61:33–38.
   PubMed Web of Science ®Google Scholar
• DUMAN RS: Synaptic plasticity and mood disorders. Mol Psychiatry (2002) 7\(Suppl. 1):529–534.
   Google Scholar
• •An interesting review on potential mechanisms for mood-stabilising properties of second-generation antipsychotic drugs.
   Google Scholar
• MILLER DS, YATHAM LN, LAM RW: Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. .1. Clin. Psychiatry (2001) 62(12):975–980.
   Google Scholar
• STRAKOWSKI SM, DELBELLO MP, ADLER C: Comparative efficacy and tolerability of drug treatments for bipolar disorder. CNS Drugs (2001) 15:701–718.
   PubMed Web of Science ®Google Scholar
• COOKSON J: Use of antipsychotic drugs and lithium in mania. Br. .1. Psychiati: Stipp]. (2001) 41:144–156.
   Google Scholar
• VIETA E, HERRAIZ M, PARRAMON G et al.: Risperidone in the treatment of mania: Efficacy and safety results from a large, multicenter, open study in Spain. .1. Affect. Disord. (2002) 72:15–19.
   Google Scholar
• AMERICAN PSYCHIATRIC ASSOCIATION: Work Group on Bipolar Disorder. Practice guideline for the treatment of patients with bipolar disorder revised. Am. J. Psychiatry(2002) 159(Suppl.):1–50.
   Google Scholar
• ••A controversial, but outstandingdocument on the treatment of BPD.
   Google Scholar
• YATHAM LN: The role of novel antipsychotics in bipolar disorders. j Clin. Psychiatry (2002) 63 (Suppl. 3):10–14.
   Google Scholar
• BOTTRI T, HOE B, HILLAIRE-BUYS D et al.: Clonazepam in acute mania: time-blind evolution of clinical response and concentrations in plasma. Affect. Disord. (1995) 36:21–27.
   PubMed Web of Science ®Google Scholar
• VIETA E: Novedades en el tratamiento del trastorno bipolar Panamericana, Madrid (2003).
   Google Scholar
• MOLLER-OERLINGHAUSEN B, RETZOW A, HENN FA et al.: Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group. Psychopharmacol (2000) 20(2):195–203.
   Google Scholar
• •The only trial looking at the added value of an anticonvulsant in patients treated with antipsychotics.
   Google Scholar
• BYMASTER FP, RASMUSSEN K, CALLIGARDO DO et al.: In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. J. Clin. Psychiatry (1997) 58 (Suppl. 10):28–36.
   Google Scholar
• BYMASTER F, PERRY KW, NELSON DL et al.: Olanzapine: a basic science update. Br. J. Psychiatry Sapp]. (1999) 37:36–40.
   Web of Science ®Google Scholar
• •A good review on the basic laboratory data regarding olanzapine.
   Google Scholar
• WADENBERG ML, SOLIMAN A, VANDERSPECK SC et al: Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology (2001) 25:633–641.
   PubMed Web of Science ®Google Scholar
• •A review on the importance of doparninergic (D2) mechanisms of antipsychotics.
   Google Scholar
• KECK PE, MCELROY SL, STRAKOWSKI SM et al.: Antipsychotics in the treatment of mood disorders and the risk for tardive dyskinesia. j Clin. Psychiatry (2000) 61 (Suppl. 4):33–38.
   Google Scholar
• ZAJECKA JM, VVEISLER R, SACHS G et al.: A comparison of the efficacy, safety and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J. Gin. Psychiatry (2002) 63(12):1148–1155.
   Google Scholar
• VIETA E: Olanzapine versus divalproex in the treatment of mania. j Clin. Psychiatry (2003) 64:1266.
   PubMedGoogle Scholar
• TOHEN M, SANGER T, MCELROY S et al.: Olanzapine versus placebo in the treatment of acute mania. Am. J. Psychiatry (1999) 156:702-709. The first published placebo-controlled trial of an atypical antipsychotic in the treatment of mania.
   Google Scholar
• TOHEN M, JACOBS TG, GRUNDY SL et al.: Efficacy of olanzapine in acute bipolar mania: a double-blind placebo controlled-study. Arch. Gen. Psychiatry (2000) 57:841–849.
   PubMed Web of Science ®Google Scholar
• TOHEN M, BAKER RW, ALTSHULER LL et al.: Olanzapine versus divalproex in the treatment of acute mania. Am. J. Psychiatry (2002) 159:1011–1017.
   PubMed Web of Science ®Google Scholar
• BERK M, ICHIM L, BROOKS: Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Clin. Psychopharmacol (1999) 14:339–343.
   Google Scholar
• TOHEN M, CHENGAPPA KN, SUPPES T et al.: Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania on patients partially nonresponsive to valproate or lithium monotherapy. Arch. Gen. Psychiatry (2002) 59(1):62–69.
   PubMed Web of Science ®Google Scholar
• •A good trial dealing with a clinically meaningful situation.
   Google Scholar
• TOHEN M, GOLDBERG JF, GONZALEZ-PINTO AM et al.: A 12-week,double-blind comparison of olanzapine versus haloperidol in the treatment of mania. Arch. Gen. Psychiatry (2003) 60:1218–1226.
   PubMed Web of Science ®Google Scholar
• BAKER RW: A three-week comparison of olanzapine versus risperidone in the treatment of bipolar mania: improvement in manic and depressive symptoms and treatment adherence. 156h Annual Meeting of the American Psychiatric Association, San Francisco, USA. May 17–22 (2003).
   Google Scholar
• MEEHAN K, ZHANG F, DAVID S et al: A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam or placebo in treating acutely agitated patients diagnosed with bipolar mania. I. Gin. Psychopharmacol (2001) 21(4):389–397.
   Web of Science ®Google Scholar
• BALDESSARINI RJ, HENNEN J, WILSON M et al.: Olanzapine versus placebo in acute mania: treatment responses in subgroups. I Clin. Psychopharmacol (2003) 23(4):370–376.
   Google Scholar
• GONZALEZ-PINTO A, LALAGUNA B, MOSQUERA F et al.: Use of olanzapine in dysphoric mania. Affect. Disord. (2001) 66:247–253.
   PubMed Web of Science ®Google Scholar
• BENAZZI F, AKISKAL HS: Clinical and factor analytic-validation of depressive mixed states: a report from the Ravenna-San Diego collaboration. Can: Opin. Psychiatry (2003) 16\(Suppl. 2):S71–S78.
   Google Scholar
• TOHEN M, VIETA E, CALABRESE JR et al.: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar depression. Arch. Gen. Psychiatry (2003) 60:1079–1088.
   PubMed Web of Science ®Google Scholar
• ••The first placebo-controlled trial of anatypical antipsychotic in the treatment of bipolar depression.
   Google Scholar
• VIETA E, REINARES M, CORBELLA B et al.: Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder. J. Clin. Psychopharmacol (2001) 21:469–473.
   PubMed Web of Science ®Google Scholar
• SANGER TM, GRUNDY SL, GIBSON PJet al.: Long-term olanzapine therapy in the treatment of bipolar disorder: an open-label continuation phase study. j Gin. Psychiatry (2001) 62:273–281.
   Google Scholar
• TOHEN M, KETTER MA, ZARATE CA et al.: Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am. J. Psychiatry (2003) 160(7):1263–1271.
   PubMed Web of Science ®Google Scholar
• TOHEN M, CHENGAPPA KNR, SUPPES T: Relapse prevention in bipolar I disorder:18-month comparison of olanzapine plus mood-stabiliser v. mood-stabiliser alone. Br. J. Psychiatry (2004) 184:337–345.
   PubMed Web of Science ®Google Scholar
• TOHEN M, MARNEROS A, BOWDEN C et al.: Olanzapine versus lithium in relapse prevention in bipolar disorder: a randomized double-blind controlled 12-month clinical trial. Bipolar Disord. (2002) 5 (Suppl.):135.
   Google Scholar
• TOHEN M: Olanzapine versus placebo in relapse prevention in bipolar disorder. 156h Annual Meeting of the American Psychiatric Association, San Francisco, USA. May 17 — 22 (2003).
   Google Scholar
• SANGER TM, TOHEN M, VIETA E et al.: Olanzapine in the treatment of acute bipolar disorder with rapid cycling. .1. Affect. Disord. (2003) 73:155–161.
   Google Scholar
• VIETA E, CARNE X: The use of placebo in clinical trials on bipolar disorders revisited: a new approach for an old debate. Psychother. Psychosom. (In Press).
   Google Scholar
• ••A review on the ethics, methodologicalissues, and predictors of response regarding placebo in BPD.
   Google Scholar
• KECK PE, CORYA SA, CALABRESE JR et al.: Acute treatment of rapid cycling bipolar I depression: a double-blind placebo controlled subanalysis of olanzapine/fluoxetine combination. .1. Affect. Disord. (In Press).
   Google Scholar
• VIETA E, CALABRESE JR, HENNEN J et al.: Comparison of rapid cycling and non-rapid cycling bipolar I manic patients with during treatment with olanzapine. j Clin. Psychiatry (In Press).
   Google Scholar
• MCINTYRE, RS: Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited. Clin. Psychiatry (2002) 63\(Suppl. 3):15–20.
   Google Scholar
• AMERICAN DIABETES ASSOCIATION, AMERICAN PSYCHIATRIC ASSOCIATION, AMERICAN ASSOCIATION OF CLINICAL ENDOCRIONOLOGISTS, NORTH AMERICAN ASSOCIATION FOR THE STUDY OF OBESITY: Consensus Development Conference in Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care (2004) 27:596–601.
   PubMed Web of Science ®Google Scholar
• ••An important document dealing withweight and metabolic concerns of atypical antipsychotics.
   Google Scholar
• VIETA E, SANCHEZ-MORENO J, GOIKOLEA JM et al.: Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder. Clin. Psychopharmacol (In Press).
   Google Scholar
• VIETA E: Atypical antipsychotics in the treatment of mood disorders. Curt: Opin. Psychiatry (2003) 16:23–27.
   Web of Science ®Google Scholar
• •A review on all the available data on atypicals in BPD.
   Google Scholar